EU and AstraZeneca reach settlement on Covid-19 vaccine supply

The settlement will help the European Union to speed up inoculations amid shortages.

The European Commission and AstraZeneca said on Friday they had reached a settlement on delivering remaining Covid-19 vaccine doses by the British drugmaker and also ended pending litigation in Brussels.

The settlement clears a major overhang for AstraZeneca, whose cheap and easily transportable vaccine has faced several setbacks, including the lawsuit and worries about possible side-effects. It also allows the European Union to speed up inoculations amid shortages.